PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32547883-0	2020	Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-kappaB and ERK pathways.	Ginsenosides	0-11	mitogen-activated protein kinase 1	Homo sapiens	98-101	
19298253-0	2009	Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells.	Ginsenosides	90-101	mitogen-activated protein kinase 1	Homo sapiens	34-38	
31301277-0	2019	Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer.	Ginsenosides	0-11	mitogen-activated protein kinase 1	Homo sapiens	95-99	
23583729-0	2013	AD-1, a novel ginsenoside derivative, shows anti-lung cancer activity via activation of p38 MAPK pathway and generation of reactive oxygen species.	Ginsenosides	14-25	mitogen-activated protein kinase 1	Homo sapiens	92-96	
25396716-12	2015	In conclusion, RGE and its ginsenosides may enhance hDPC proliferation, activate ERK and AKT signaling pathways in hDPCs, upregulate hair matrix keratinocyte proliferation, and inhibit the DHT-induced androgen receptor transcription.	Ginsenosides	27-39	mitogen-activated protein kinase 1	Homo sapiens	81-84	
25337569-0	2014	Ginsenoside Rg3 Inhibits Constitutive Activation of NF-kappaB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets.	Ginsenosides	0-11	mitogen-activated protein kinase 1	Homo sapiens	115-118